Literature DB >> 23473716

Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.

Kallirhoe Kalinderi1, Sevasti Bostantjopoulou, Zoe Katsarou, Liana Fidani.   

Abstract

In a recent web based genome-wide association study (GWA) the rs6812193 polymorphism was identified as a new risk factor for Parkinson's disease (PD). The purpose of our study was to examine the association of the rs6812193 polymorphism with Parkinson's disease (PD) in case-control association study of Greek individuals. We studied a total of 343 individuals, 210 Greek patients with sporadic PD and 133 control subjects, using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. We found no differences in genotype or allele frequencies between PD patients and controls (P=0.795 and P=0.892, respectively), suggesting that the rs6812193 polymorphism does not increase susceptibility to PD in the Greek population. Additional studies further investigating the association of the rs6812193 polymorphism with PD are needed in order to clarify the role of this polymorphism in different ethnicities.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473716     DOI: 10.1016/j.neulet.2013.02.048

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Association between rs6812193 polymorphism and sporadic Parkinson's disease susceptibility.

Authors:  Qiang Huo; Tao Li; Peiqing Zhao; Lianqing Wang
Journal:  Neurol Sci       Date:  2015-03-29       Impact factor: 3.307

2.  No association of FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 polymorphisms with Parkinson's disease in a Chinese Han population.

Authors:  YongPing Chen; XiaoQin Yuan; Bei Cao; QianQian Wei; RuWei Ou; Jing Yang; XuePing Chen; Bi Zhao; Wei Song; Ying Wu; HuiFang Shang
Journal:  J Neural Transm (Vienna)       Date:  2015-07-30       Impact factor: 3.575

3.  Relationship between polymorphism of receptor SCARB2 gene and clinical severity of enterovirus-71 associated hand-foot-mouth disease.

Authors:  Xia Wang; Hong Liu; Ying Li; Rui Su; Yamin Liu; Kunyan Qiao
Journal:  Virol J       Date:  2021-06-30       Impact factor: 4.099

4.  SCARB2 variants and glucocerebrosidase activity in Parkinson's disease.

Authors:  Roy N Alcalay; Oren A Levy; Pavlina Wolf; Petra Oliva; Xiaokui Kate Zhang; Cheryl H Waters; Stanley Fahn; Un Kang; Christopher Liong; Blair Ford; Pietro Mazzoni; Sheng Kuo; Amelie Johnson; Lan Xiong; Guy A Rouleau; Wendy Chung; Karen S Marder; Ziv Gan-Or
Journal:  NPJ Parkinsons Dis       Date:  2016-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.